{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:26:16Z","timestamp":1792808776510,"version":"4.5.0"},"reference-count":93,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21790"],"award-info":[{"award-number":["21790"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministero dell'Universit\u00e0 e della Ricerca","award":["2017YTWKWH"],"award-info":[{"award-number":["2017YTWKWH"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thyroid carcinoma is the most frequent endocrine neoplasia. Different types of thyroid carcinoma are described: well-differentiated papillary thyroid carcinoma (PTC), poorly differentiated thyroid carcinoma (PDTC), follicular thyroid carcinoma (FTC), anaplastic thyroid carcinoma (ATC), and medullary thyroid carcinoma (MTC). MTC is inherited as an autosomal dominant trait in 25% of cases. The genetic landscape of thyroid carcinoma has been largely deciphered. In PTC, genetic alterations have been found in about 95% of tumors: BRAF mutations and RET rearrangements are the main genetic alterations. BRAF and RAS mutations have been confirmed to play an important role also in PDTC and ATC, together with TP53 mutations that are fundamental in tumor progression. It has also been clearly demonstrated that telomerase reverse transcriptase (TERT) promoter mutations and TP53 mutations are present with a high-frequency in more advanced tumors, frequently associated with other mutations, and their presence, especially if simultaneous, is a signature of aggressiveness. In MTC, next-generation sequencing confirmed that mutations in the RET gene are the most common molecular events followed by H-RAS and K-RAS mutations. The comprehensive knowledge of the genetic events responsible for thyroid tumorigenesis is important to better predict the biological behavior and better plan the therapeutic strategy for specific treatment of the malignancy based on its molecular profile.<\/jats:p>","DOI":"10.3390\/ijms22041726","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T23:43:16Z","timestamp":1612914196000},"page":"1726","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer"],"prefix":"10.3390","volume":"22","author":[{"given":"Cristina","family":"Romei","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Endocrinology, University of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Elisei","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Endocrinology, University of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and Clinical Perspectives on Thyroid Cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Romei, C., Pardi, E., Cetani, F., and Elisei, R. (2012). Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2. J. Oncol., 1\u201315.","DOI":"10.1155\/2012\/705036"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1210\/jc.2012-2703","article-title":"Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS","volume":"98","author":"Agrawal","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-014-1589-3","article-title":"High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas","volume":"465","author":"Simbolo","year":"2014","journal-title":"Virchows Arch."},{"key":"ref_7","first-page":"170","article-title":"A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases","volume":"328","author":"Fusco","year":"1987","journal-title":"Nat. Cell Biol."},{"key":"ref_8","first-page":"509","article-title":"Molecular characterization of RET\/PTC3; A novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma","volume":"9","author":"Santoro","year":"1994","journal-title":"Oncogene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_10","first-page":"3211","article-title":"RET\/PTC Rearrangements in Thyroid Nodules: Studies in Irradiated and Not Irradiated, Malignant and Benign Thyroid Lesions in Children and Adults1","volume":"86","author":"Elisei","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","first-page":"1690","article-title":"Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children","volume":"57","author":"Nikiforov","year":"1997","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1126\/science.290.5489.138","article-title":"Proximity of Chromosomal Loci That Participate in Radiation-Induced Rearrangements in Human Cells","volume":"290","author":"Nikiforova","year":"2000","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2009.09.013","article-title":"Mechanisms of chromosomal rearrangements in solid tumors: The model of papillary thyroid carcinoma","volume":"321","author":"Gandhi","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/sj.onc.1209268","article-title":"Interphase chromosome folding determines spatial proximity of genes participating in carcinogenic RET\/PTC rearrangements","volume":"25","author":"Gandhi","year":"2005","journal-title":"Oncogene"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/gcc.21988","article-title":"Frequency of close positioning of chromosomal loci detected by FRET correlates with their participation in carcinogenic rearrangements in human cells","volume":"51","author":"Gandhi","year":"2012","journal-title":"Genes. Chromosom. Cancer"},{"key":"ref_16","first-page":"200","article-title":"Differentiated thyroid cancer in children and adults: Same or distinct disease?","volume":"6","author":"Jarzab","year":"2007","journal-title":"Hormones"},{"key":"ref_17","first-page":"1093","article-title":"Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: Biological, phenotypic, and clinical implications","volume":"6","author":"Rabes","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E1758","DOI":"10.1210\/jc.2012-1269","article-title":"Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years","volume":"97","author":"Romei","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1507\/endocrj.K10E-260","article-title":"Prevalence of RET\/PTC rearrangement in benign and malignant thyroid nodules and its clinical application","volume":"58","author":"Guerra","year":"2011","journal-title":"Endocr. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/106689690000800305","article-title":"Ret\/PTC-1 Activation in Hashimoto Thyroiditis","volume":"8","author":"Sheils","year":"2000","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/SLA.0000000000001420","article-title":"Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: A study of 1510 patients","volume":"262","author":"Yip","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<71::AID-PATH42>3.0.CO;2-S","article-title":"Sporadic ret-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?","volume":"185","author":"Soares","year":"1998","journal-title":"J. Pathol."},{"key":"ref_23","first-page":"4232","article-title":"High Prevalence of RET\/PTC Rearrangements in Ukrainian and Belarussian Post-Chernobyl Thyroid Papillary Carcinomas: A Strong Correlation between RET\/PTC3 and the Solid-Follicular Variant1","volume":"84","author":"Thomas","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/ERC-07-0130","article-title":"BRAFV600E mutation, but not RET\/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer","volume":"15","author":"Romei","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2559.2010.03646.x","article-title":"RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components","volume":"57","author":"Mochizuki","year":"2010","journal-title":"Histopathology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI23237","article-title":"Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer","volume":"115","author":"Ciampi","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00000478-200208000-00006","article-title":"PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses","volume":"26","author":"Nikiforova","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/his.12150","article-title":"Diagnostic and prognostic implications of the PAX8-PPAR\u03b3 translocation in thyroid carcinomas-a TMA-based study of 226 cases","volume":"63","author":"Boos","year":"2013","journal-title":"Histopathology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1210\/jc.2016-1775","article-title":"Papillary Thyroid Carcinoma with Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience","volume":"101","author":"Torregrossa","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"McKelvey, B.A., Zeiger, M.A., and Umbricht, C.B. (2020). Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study. Genes Chromosom. Cancer, 122.","DOI":"10.1002\/gcc.22928"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E276","DOI":"10.1210\/jc.2013-2503","article-title":"The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations","volume":"99","author":"Jung","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/106689690501300101","article-title":"Ret\/PTC and BRAF Act as Distinct Molecular, Time-Dependant Triggers in a Sporadic Irish Cohort of Papillary Thyroid Carcinoma","volume":"13","author":"Smyth","year":"2005","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.18632\/oncotarget.12885","article-title":"The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: A systematic review","volume":"8","author":"Vuong","year":"2016","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1210\/jc.2008-2390","article-title":"Association of High Iodine Intake with the T1799A BRAF Mutation in Papillary Thyroid Cancer","volume":"94","author":"Guan","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/jnci\/djp354","article-title":"Papillary Thyroid Cancer Incidence in the Volcanic Area of Sicily","volume":"101","author":"Pellegriti","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1210\/jc.2011-3106","article-title":"A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome","volume":"97","author":"Guerra","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/jc.2011-0618","article-title":"The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma","volume":"97","author":"Guerra","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/ERC-14-0147","article-title":"Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression","volume":"21","author":"Kim","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1210\/jc.2015-4031","article-title":"Subclonality for BRAF Mutation in Papillary Thyroid Carcinoma Is Associated with Earlier Disease Stage","volume":"101","author":"Finkel","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/jc.2012-2201","article-title":"BRAFV600E mutation and papillary thyroid cancer: Chicken or egg?","volume":"97","author":"Xing","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1210\/jc.2004-2353","article-title":"High Prevalence and Possible de Novo Formation of BRAF Mutation in Metastasized Papillary Thyroid Cancer in Lymph Nodes","volume":"90","author":"Vasko","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-020-00378-z","article-title":"Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma","volume":"21","author":"Ha","year":"2021","journal-title":"Cancer Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1210\/jc.2008-0607","article-title":"BRAFV600Emutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2012-1775","article-title":"TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study","volume":"97","author":"Elisei","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MD.0b013e31826a9c71","article-title":"BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: A systematic review and meta-analysis","volume":"91","author":"Tufano","year":"2012","journal-title":"Medicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association Between BRAF V600E Mutation and Mortality in Patients with Papillary Thyroid Cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2005.02389.x","article-title":"The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma","volume":"63","author":"Kim","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2265.2005.02367.x","article-title":"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan","volume":"63","author":"Liu","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2015.0227","article-title":"Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation","volume":"26","author":"Afkhami","year":"2016","journal-title":"Thyroid"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/thy.2015.0506","article-title":"Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAFV600E Mutation-Prevalent Area","volume":"26","author":"Jeon","year":"2016","journal-title":"Thyroid"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/hmg\/ddu749","article-title":"Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing","volume":"24","author":"Kunstman","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1210\/jc.2003-030838","article-title":"BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0092-8674(04)00053-4","article-title":"Tracking telomerase","volume":"116","author":"Greider","year":"2004","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg1656","article-title":"Telomeres and human disease: Ageing, cancer and beyond","volume":"6","author":"Blasco","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.7544491","article-title":"The RNA component of human telomerase","volume":"269","author":"Feng","year":"1995","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-5793(04)00356-4","article-title":"On the road to immortality: hTERT upregulation in cancer cells","volume":"564","author":"Janknecht","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT Promoter Mutations in Familial and Sporadic Melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly Recurrent TERT Promoter Mutations in Human Melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","article-title":"TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer","volume":"99","author":"Liu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Yoo, S.-K., Lee, S., Kim, S.-J., Jee, H.-G., Kim, B.-A., Cho, H., Song, Y.S., Cho, S.W., Won, J.-K., and Shin, J.-Y. (2016). Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1006239"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrendo.2017.76","article-title":"Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies","volume":"13","author":"Molinaro","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/thy.2011.0261","article-title":"The association between RAS gene mutations and clinical characteristics in follicular thyroid tumors: New insights from a single center and a large patient cohort","volume":"22","author":"Fukahori","year":"2012","journal-title":"Thyroid"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2018-00277","article-title":"Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology","volume":"103","author":"Nicolson","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/ERC-16-0043","article-title":"Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules","volume":"23","author":"Karunamurthy","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138920211798120853","article-title":"Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas","volume":"12","author":"Soares","year":"2011","journal-title":"Curr. Genom."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1530\/EJE-15-0605","article-title":"Endocrine tumours: Genetic predictors of thyroid cancer outcome","volume":"174","author":"Tavares","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1172\/JCI116385","article-title":"Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland","volume":"91","author":"Donghi","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI116168","article-title":"High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas","volume":"91","author":"Fagin","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_71","first-page":"9174","article-title":"Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience","volume":"15","author":"Romei","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"175","DOI":"10.31662\/jmaj.2020-0021","article-title":"Roles of the RET Proto-oncogene in Cancer and Development","volume":"3","author":"Takahashi","year":"2020","journal-title":"JMA J."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ji, J.H., Oh, Y.L., Hong, M., Yun, J.W., Lee, H.-W., Kim, D., Ji, Y., Kim, D.-H., Park, W.-Y., and Shin, H.-T. (2015). Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005467"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1210\/jc.2014-4153","article-title":"RET fusion as a novel driver of medullary thyroid carcinoma","volume":"100","author":"Grubbs","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_75","first-page":"458","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nat. Cell Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/hmg\/ddw057","article-title":"Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression","volume":"25","author":"Smith","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1089\/thy.2017.0171","article-title":"ESR2 Gene and Medullary Thyroid Carcinoma","volume":"27","author":"Navarro","year":"2017","journal-title":"Thyroid"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update","volume":"98","author":"Wells","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association","volume":"19","author":"Chair","year":"2009","journal-title":"Thyroid"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-11-0117","article-title":"In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer","volume":"18","author":"Cosci","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1002\/cncr.30252","article-title":"Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer","volume":"122","author":"Sherman","year":"2016","journal-title":"Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmedgenet-2016-103833","article-title":"New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations","volume":"53","author":"Romei","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ciampi, R., Mian, C., Fugazzola, L., Cosci, B., Romei, C., Barollo, S., Cirello, V., Bottici, V., Marconcini, G., and Pelizzo, M.R. (2012). Evidence of a low prevalence of ras mutations in a large medullary thyroid cancer series. Thyroid, 23.","DOI":"10.1089\/thy.2012-0207"},{"key":"ref_87","first-page":"2167","article-title":"Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma","volume":"56","author":"Eng","year":"1996","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.18632\/oncotarget.23986","article-title":"RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases","volume":"9","author":"Romei","year":"2018","journal-title":"Oncotarget"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/thy.2011.0358","article-title":"Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer","volume":"22","author":"Romei","year":"2012","journal-title":"Thyroid"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","article-title":"Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10-year follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1530\/EJE-11-0079","article-title":"Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: A useful tool for patient risk stratification","volume":"164","author":"Mian","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2010-1921","article-title":"High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas","volume":"96","author":"Moura","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"E2031","DOI":"10.1210\/jc.2012-2092","article-title":"Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon","volume":"97","author":"Boichard","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1726\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:21:49Z","timestamp":1760160109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":93,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22041726"],"URL":"https:\/\/doi.org\/10.3390\/ijms22041726","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,9]]}}}